Surpass, Inc

Our innovative approach to preclinical research goes beyond the ordinary. Were changing the rules for a better way to get from concept to reality. Surpass is a preclinical contract research organization (CRO) with extensive experience conducting medical device, pharmaceutical, biotech and combination product studies with specialized expertise in surgical and interventional procedures. Our testing services include early feasibility, product development, GLP, and physician/clinical training studies with in vivo models and human cadavers. Surpass AAALAC-accredited facilities in the Midwest Greater Twin Cities area provide spacious surgical suites with hospital-grade equipment (flat panel cath labs, portable c-arms, cardiopulmonary bypass machines, ultrasound systems,...

Preclinical model development,experimental surgery,nonclinical safety good laboratory practice (glp) testing,physician and clinical bio-skills training,preclinical r&d testing,non-glp feasibility and product development testing,and pharmacokinetic (pk) studies

Surpass, inc operates in the Research services industry.

Surpass, inc's revenue is 11m - 100m

Surpass, inc has 11 - 50 employees.